CJC-1295 With DAC

CJC-1295 With DAC is a modified form of the synthetic peptide CJC-1295, specifically engineered to lack the decapeptide D-Ala29 (DAC). This variant is often used in preclinical research to study the physiological and pharmacological effects of the peptide with the influence of its DAC-modified counterpart.

Research Context

CJC-1295 is a growth hormone-releasing peptide (GHRP) developed for its ability to stimulate growth hormone secretion. Originally formulated with DAC, which modifies the peptide to enhance its stability and pharmacokinetic properties, the removal of DAC introduces a distinct profile for research applications. The variant with DAC retains the core structural and functional characteristics of CJC-1295, enabling researchers to investigate the peptide’s effects in a more natural form.

Research Overview

CJC-1295 With DAC is primarily utilized in scientific studies to evaluate its impact on various biological systems. This includes assessments of neuroendocrine regulation, metabolic processes, and potential therapeutic mechanisms in controlled experimental settings. Given its structural differences from the DAC-modified version, this peptide variant offers a valuable tool for researchers studying the distinct biological pathways activated by CJC-1295 with DAC.

Key Research Focus Areas

• • Hormonal Regulation:

Investigation of its effects on growth hormone secretion, insulin-like growth factor 1 (IGF-1) production, and related endocrine functions.

• • Neuroendocrine Effects:

Exploration of its influence on hypothalamus-pituitary-adrenal (HPA) axis activity, potential neuroprotective properties, and interactions with other neuropeptides.

• • Metabolic Studies:

Assessment of its role in glucose metabolism, energy homeostasis, and potential implications for obesity or weight management research.

• • Pharmacokinetics and Biotransformation:

Evaluation of the metabolic clearance, binding affinity, and stability of CJC-1295 With DAC compared to its DAC-modified counterpart.

• • Therapeutic Mechanisms:

Investigation of its potential use in preclinical models to study disease mechanisms, such as cancer research or regenerative biology, in the absence of DAC-mediated modifications.

Important Compliance Note

For research use only. Not for human or animal consumption. CJC-1295 With DAC is intended exclusively for use in academic, industrial, or institutional research settings under the supervision of qualified personnel. Any use beyond research purposes, including therapeutic or cosmetic applications, is strictly prohibited. Always adhere to applicable laws, regulations, and ethical guidelines governing the handling and storage of research materials.